DrugPatentWatch Database Preview

Apomorphine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for apomorphine hydrochloride and what is the scope of apomorphine hydrochloride patent protection?

Apomorphine hydrochloride is the generic ingredient in one branded drug marketed by Us Worldmeds and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for apomorphine hydrochloride. One supplier is listed for this compound.

Summary for apomorphine hydrochloride

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	6
Suppliers / Packagers:	1
Bulk Api Vendors:	43
Clinical Trials:	36
Patent Applications:	5,413
Formulation / Manufacturing:	see details
DailyMed Link:	apomorphine hydrochloride at DailyMed

Pharmacology for apomorphine hydrochloride

Drug Class	Dopaminergic Agonist
Mechanism of Action	Dopamine Agonists

Medical Subject Heading (MeSH) Categories for apomorphine hydrochloride

Dopamine Agonists

Emetics

Synonyms for apomorphine hydrochloride

(-)-10,11-Dihydroxyaporphine

(-)-Apomorphine

(-)-Apomorphine (hydrochloride)

(-)-Apomorphine hydrochloride

(-)-Apomorphinium hydrochloride

(-)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(APO)

(6aR)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol

(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride

(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydrate;hydrochloride

(9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaene-3,4-diol

(9R)-10-methyl-10-azatetracyclo[7.7.1.0;{2,7}.0;{13,17}]heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol

(Apomorphine) 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

(apomorphine)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

(R)-(-)-Apomorphine

(R)-(-)-apomorphine HCl

(R)-(-)-Apomorphine hydrochloride

(R)-5,6,6A,7-TETRAHYDRO-6-METHYL-4H-DIBENZO[DE-G]QUINOLINE-10,11-DIOL

(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride

(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine)

(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol (apomorphine)

(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(apomorphine)

(R)-Apomorphine

314-19-2

314-19-2 (hydrochloride anhydrous)

372A207

41372-20-7

41372-20-7 (hydrochloride hemihydrate)

4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)-

4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)- (9CI)

4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride (1:1), (6aR)-

4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (6aR)-

4H-Dibenzo[de,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (R)-

5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol hydrochlorid

58-00-4

58-00-4 (Parent)

5896-07-1

6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine)

6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol((R)-apomorphine)

6a-beta-Aporphine-10,11-diol

6a-beta-Aporphine-10,11-diol, hydrochloride

6a-beta-Noraporphine-10,11-diol, 6-methyl-, hydrochloride

6a.beta.-Aporphine-10, hydrochloride

6a.beta.-Noraporphine-10, 6-methyl-, hydrochloride

6abeta-Aporphine-10,11-diol

6abeta-Aporphine-10,11-diol, hydrochloride

6abeta-Aporphine-10,11-diol, hydrochloride (8CI)

6abeta-Noraporphine-10,11-diol, 6-methyl-, hydrochloride

8233AH

9K13MD7A0D

AC1L1LLC

AC1L1SZ7

AC1Q3F8P

AKOS024456928

API0001523

Apokyn

Apomorfin

Apomorphin

Apomorphin hydrochlorid

apomorphine

Apomorphine (BAN)

Apomorphine (intranasal, Parkinson's disease)

Apomorphine (R,-)

Apomorphine [BAN]

Apomorphine chloride

Apomorphine HCl

Apomorphine Hydrochloride (anhydrous)

Apomorphine hydrochloride (R,-)

Apomorphine hydrochloride anhydrous

Apomorphine hydrochloride hemihydrate

Apomorphine hydrochloride hydrate

Apomorphine Hydrochloride, Anhydrous

Apomorphine SL

apomorphine-hcl

APOMORPHINE, HYDROCHLORIDE

APOMORPHINE6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

APOMORPHINEHYDROCHLORIDE

Apomorphinium chloride

Apomorphinium chloride hemihydrate

Apomorphinum hydrochloricum

Apormorphine

B6936

BB_NC-0484

BDBM29644

BDBM50001955

BG0043

Biomol-NT_000019

BPBio1_000092

BPBio1_001179

BRD-K76022557-001-01-3

BRD-K76022557-311-20-6

BSPBio_000082

C17H17NO2

C17H17NO2.HCl

CAS-58-00-4

CHEBI:48538

CHEMBL1616

CHEMBL53

cid_6852399

CTK8F2000

D07460

D0B6QP

D0H6QU

DB00714

DSSTox_CID_2614

DSSTox_GSID_22614

DSSTox_RID_76660

DTXSID5040598

DTXSID8022614

EINECS 200-360-0

EINECS 206-243-0

FT-0602881

GTPL33

H72A207

HMS2089C10

HSDB 3289

IV Apomorphine

Ixense

J-018414

L-Apomorphine

LS-21474

LS-61218

MCULE-1576765478

MCULE-3200317958

MolPort-003-983-404

N-Methylnorapomorphine hydrochloride

N21FAR7B4S

NCGC00025349-01

NCGC00025349-02

NCGC00025349-03

NCGC00025349-04

NCGC00025349-05

NH001

NSC 11442

NSC-11442

NSC11442

PDSP1_000780

PDSP2_001488

pomorphini hydrochloridum

Prestwick_28

Prestwick0_000101

Prestwick1_000101

Prestwick2_000101

Prestwick3_000101

Q-200645

R-(-)-Apomorphine

R-(-)-apomorphine HCl

R-(-)-Apomorphine hydrochloride

R( C)-10,11- paragraph signthornoC>>u degrees centAEO.E

R( C)-APO

SCHEMBL8524

SCHEMBL8541

SKYZYDSNJIOXRL-BTQNPOSSSA-N

SMP1_000027

SPBio_002021

SR-01000597777

SR-01000597777-1

STOCK1N-03149

Tocris-2073

Tox21_110967

Tox21_110967_1

UNII-9K13MD7A0D

UNII-N21FAR7B4S

Uprima

Uprima (TN)

VMWNQDUVQKEIOC-CYBMUJFWSA-N

VR-040

VR-400

VR004

WLN: T C6666 1A Q KN & TT & J DQ EQ K1 & GH

ZINC9073

US Patents and Regulatory Information for apomorphine hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Us Worldmeds	APOKYN	apomorphine hydrochloride	INJECTABLE;SUBCUTANEOUS	021264-002	Apr 20, 2004		RX	Yes	Yes
Us Worldmeds	APOKYN	apomorphine hydrochloride	INJECTABLE;SUBCUTANEOUS	021264-001	Apr 20, 2004		DISCN	No	No